Acute Myeloid Leukemia

Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...

In this video, Alexander Khoruts, MD, talks about his team's randomized, double-blind study, which showed that fecal microbiota transplant therapy is safe to use for patients with acute myeloid leukemia...

In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...

In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...

In this video, Kendall Diebold, DNP, FNP-C, speaks about her team’s research titled “Outcomes of 3- Versus 5-Day Administration Schedule of Consolidation Cytarabine in Adults with Acute Myeloid Leukemia,”...

In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...